IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx to Participate in Upcoming Investor Conferences Read more about Ardelyx to Participate in Upcoming Investor Conferences Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights Read more about Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference Read more about Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference Ardelyx to Report Second Quarter 2022 Financial Results on August 4, 2022 Read more about Ardelyx to Report Second Quarter 2022 Financial Results on August 4, 2022 Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners Read more about Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 Read more about Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 Ardelyx to Present at the Jefferies 2022 Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2022 Healthcare Conference Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults Read more about Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx to Participate in Upcoming Investor Conferences Read more about Ardelyx to Participate in Upcoming Investor Conferences
Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights Read more about Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference Read more about Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference
Ardelyx to Report Second Quarter 2022 Financial Results on August 4, 2022 Read more about Ardelyx to Report Second Quarter 2022 Financial Results on August 4, 2022
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners Read more about Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 Read more about Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022
Ardelyx to Present at the Jefferies 2022 Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2022 Healthcare Conference
Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults Read more about Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults